JPMorgan’s $262 Palantir target needs 59% annual cash flow growth
The target needs Palantir's free cash flow to grow about 59% a year to 2028. The stock trades near 40 times that cash flow today, and the target pays 55 times.
JPMorgan has put a price on Palantir's next two years of cash flow. The 2 November results are the first test of whether that price holds. On 29 October analyst Brian Essex initiated coverage at Overweight with a $262 target. CNBC reports the target is 33% above Wednesday's close.
Essex wrote that Palantir "is already delivering ROI by leveraging its platform to fundamentally transform the business operations of its customers, and growth is accelerating." The valuation requires more demanding assumptions. Investing.com reports a December 2027 target built on 2028 cash flow.
The target equals 55 times calendar 2028 enterprise value to free cash flow, on $11.7bn of free cash flow, Investing.com reports. Enterprise value is the market value of the shares less cash. Palantir's balance sheet lists no borrowings.
The cash flow growth required
Palantir's own guidance shows how far away that cash flow is. It guides adjusted free cash flow of $4.5bn to $4.7bn for 2026.
The midpoint is $4.6bn. The gap to $11.7bn is $7.1bn of extra annual cash flow within two years.
Reaching $11.7bn in 2028 means multiplying the midpoint by about 2.5 in two years. That is roughly 59% a year, or 58% to 61% across the guided range. These sums are arithmetic on guidance. JPMorgan models growth that slows, with a 77% compound rate over the three years to 2028.
The revenue needed is also large. Palantir's second quarter adjusted free cash flow margin was 63%. At that margin, $11.7bn of cash flow needs about $18.6bn of 2028 revenue, 2.3 times the $8.150bn to $8.158bn guided for 2026.
That needs revenue growth of about 51% a year for two years from the 2026 guide. Palantir has raised that guide twice, from 61% growth in February to 71% in May and 82% in August.
The valuation at today’s price and at $262
On reported share counts, the stock trades near 40 times that cash flow. Palantir's second quarter release shows 2.40bn weighted basic shares and 2.57bn diluted. Google Finance showed a price of $194 and a market value of $466bn on 29 October.
Cash is small beside the valuation. The $9.2bn of cash and Treasuries held at 30 June is about 2% of the $466bn market value. The multiple rests almost entirely on the shares.
Take that cash off. Enterprise value is about $457bn on basic shares, 39 times $11.7bn. On diluted shares it is about $489bn, 42 times.
The same counts at $262 give 53 times on basic shares and 57 times on diluted. JPMorgan's 55 times sits between them.
The target therefore needs the multiple to rise from about 40 to 55 times, on top of the 59% growth. It is also 23% above the 52-week high of $212.94.
What the business is delivering
The business is growing fast. Second quarter revenue rose 93% to $1.935bn, and US commercial revenue rose 149% to $764mn. Adjusted operating margin was 62%.
Adjusted free cash flow was $1.220bn, up 115% from $569mn a year earlier. One quarter delivered about 27% of the $4.6bn guided midpoint for the year. Four quarters at that rate would be about $4.9bn, above the top of the 2026 guide.
Palantir reports a Rule of 40 score of 155%. That is revenue growth of 93% plus adjusted operating margin of 62%.
Sales and marketing cost $340mn in the quarter, 18% of revenue, against $244mn and 24% a year earlier. Revenue rose faster than the cost of selling it, which lifts the margin.
The revenue guide needs $4.59bn in the second half, 29% above the first half's $3.568bn. With $2.16bn guided for the third quarter, the fourth must reach $2.42bn, 12% above the third.
US government revenue rose 90% to $809mn, slightly more than US commercial. Total US revenue grew 115% to $1.573bn.
Revenue growth has risen for nine straight quarters. It went from 21% in the first quarter of 2024 to 93% in the second quarter of 2026, according to Palantir's earnings releases.
Contracts and stock awards
Palantir closed $3.373bn of total contract value, up 49%. That included a record $2.132bn in US commercial, up 153%.
It signed 220 deals of at least $1mn, 98 of at least $5mn and 73 of at least $10mn. Large contracts are the unit that builds the backlog below.
US commercial remaining deal value reached $6.238bn, up 124%. That is about eight quarters of second quarter US commercial revenue. Palantir guides US commercial revenue above $3.424bn for 2026, growth of at least 134%.
Adjusted free cash flow adds back stock awards: $265mn in the quarter, 22% of the total. Basic weighted shares are up 1.5% from a year earlier, so cash flow per share grows a little slower than the total.
Wall Street already leans this way. Of 35 analysts, 26 rate Palantir a buy or strong buy, according to LSEG data cited by CNBC. Oppenheimer raised its target to $235 from $200 the same day, and MarketScreener puts the mean target at about $209.
What to watch on 2 November
Two numbers will shape the read on 2 November. US commercial remaining deal value must keep compounding from $6.238bn. Diluted shares, 2.57bn in the second quarter, show what stock awards cost holders.
Palantir reports third quarter results after the close on Monday 2 November, as listed on its investor events page. It guides revenue of $2.160bn to $2.164bn.
The 2026 cash flow guide sits below the second quarter pace. Its $4.6bn midpoint is 56% of guided revenue, and the quarter delivered 63%. Adjusted operating income is guided at $4.889bn to $4.897bn, about 60% of revenue.
An even 59% pace would put 2027 free cash flow near $7.3bn, about $2.7bn above the 2026 midpoint. The second year of the path is the larger step.
Second quarter cash flow already annualises to $4.9bn, so a raised 2026 guide is possible. Every $100mn added to the 2026 base lowers the growth JPMorgan needs by about 1.7 points a year. If the guide holds at $4.5bn to $4.7bn, 58% to 61% a year remains to be found in 2027 and 2028.